Showing results (291-300 of 354) with videos related to

Sort By:
Pageof 36
Urology|March 15, 2001
Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeonsP C Walsh, P Marschke, W J Catalona, et al.
The Journal of Urology|March 1, 1995
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 diseaseM J Carmichael, R W Veltri, A W Partin, et al.
Urology|November 1, 1994
Concordance rates for benign prostatic disease among twins suggest hereditary influenceA W Partin, W F Page, B R Lee, et al.
The Journal of Urology|April 1, 1989
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasiaJ P Weber, J E Oesterling, C A Peters, et al.
Progress in Clinical and Biological Research|January 1, 1989
The value of prostate-specific antigen in the management of localized prostatic cancerP C Walsh, J E Oesterling, J I Epstein, et al.
Maryland Medical Journal (Baltimore, Md. : 1985)|April 1, 1990
Preservation of sexual function in men during radical pelvic surgeryP C Walsh, C B Brendler, T Chang, et al.
Urology|November 9, 2000
Today men with prostate cancer have larger prostatesM R Feneley, P Landis, I Simon, et al.
The Journal of Urology|August 1, 1988
A prototype device for nonimmersion shock wave lithotripsy using ultrasonography for calculus localizationF F Marshall, F Weiskopf, A Singh, et al.
Urology|January 11, 2000
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomyM Han, P B Snow, J I Epstein, et al.
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
Pageof 36